Search Results 691-700 of 13353 for Assay

1. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

   difficile infection recurrences with a positive stool assay for C. difficile were included. After standard-of-care antibiotics, participants randomly ...

2. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   A negative QuantiFERON® TB-Gold In-Tube test (or centrally reported equivalent assay) at screening; AND; A chest radiograph (views as per local guidelines) ...

3. Clinical trials - Oncology (Medical)

   ... assayed from blood of cases with CAP and controls without history of cancer. Pagination Clinical studies. PrevPrevious Page · Go to page 55 · Go to page 66 · Go ...

4. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

   Has laboratory-confirmed (within 14 days prior to enrollment) SARS-CoV-2 infection as determined by PCR or other commercial or public health assay in any ...

5. Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT) - Mayo Clinic

   Positive baseline serum Platelia GM EIA (≥ 0.5) and/or ?-D glucan assay (Fungitell ≥80 picograms \[pg\]/mL or Fujifilm Wako \>11 pg/mL) within 15 days ...

6. Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions - Mayo Clinic

   ... assays] or FGFR pathway mutation/amplification [using next-gen sequencing assays (such as Foundation One)]; assays must be performed in a Clinical ...

7. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaped/Refractory Multiple Myeloma - Mayo Clinic

   Serum free light chain (FLC) assay: Involved FLC level ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65) 5. Resolved acute effects of ...

8. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

   evidence of such abuse as indicated by the laboratory assays conducted during screening. 16. The Investigator should be guided by the following criteria ...

9. Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial - Mayo Clinic

   ... assays are performed. Chosen ECOG treatment clinical trial must be active and accruing. Patient must not have begun treatment on the ECOG treatment clinical ...

10. Scientific and clinical advances aid in diagnosis, staging and treatment of cholangiocarcinoma

    Assays measuring circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) are emerging as clinical tools for detection and monitoring of the disease.